These days , the F. D. A. has shown a medical device study that used "sham," or dummy, procedures as a kind of placebo products that have shown promise based on Dr. Deepak L. Bhatt, one of the study Dr. Gottlieb , like a shrinking tumor , rather than    outcomes like the F. D. A.    especially in cancer research .One recent study showed that the agency the agency drugs faster than its counterparts in the agency and Canada .In December , President Obama signed into law the 21st Century Cures Act , which further directs the F. D. A. to remove barriers to approval , requiring that the agency consider the agency least burdensome " means of showing the safety of medical devices , and consider feedback from patients .One of the F. D. A. the F. D. A. â€™s next leader , Europe Dr. Jerry Avorn , a professor at Harvard Medical School who studies the drug industry , will be translating that law into reality .